SKI Market

A+| A| A-|

Indian Indices

Sensex

76,922.64 443.97
( 0.58%)

Global Indices

Nasdaq

52,316.93 113.19
(0.22%)

Dow Jones

7,516.83 55.40
(0.74%)

Hang Seng

70,577.01 514.69
(0.73%)

Nikkei 225

10,484.10 -13.02
(-0.12%)

Forex

USD-INR

94.49 0.37
(0.39%)

EUR-INR

107.78 0.64
(0.60%)

GBP-INR

125.01 0.85
(0.69%)

JPY-INR

0.58 0.00
(0.33%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Solara Active Pharma Sciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

541540

INE624Z01016

263.4170323

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SOLARA

2757.38

EPS(TTM)

Face Value()

Div & Yield %

Back

Consolidated Finvest & Holdings standalone net profit declines 21.42% in the December 2025 quarter

Feb 14,2026

Net profit of Consolidated Finvest & Holdings declined 21.42% to Rs 11.96 crore in the quarter ended December 2025 as against Rs 15.22 crore during the previous quarter ended December 2024. Sales declined 6.29% to Rs 13.27 crore in the quarter ended December 2025 as against Rs 14.16 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	13.27	14.16	-6
OPM %	98.87	98.94	-
PBDT	13.46	17.16	-22
PBT	13.46	17.16	-22
NP	11.96	15.22	-21

76,922.64 443.97 ( 0.58%)

52,316.93 113.19 (0.22%)

7,516.83 55.40 (0.74%)

70,577.01 514.69 (0.73%)

10,484.10 -13.02 (-0.12%)

94.49 0.37 (0.39%)

107.78 0.64 (0.60%)

125.01 0.85 (0.69%)

0.58 0.00 (0.33%)